Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 20.75
+0.93 (4.69%)
At close: Mar 6, 2026
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.39 billion as of March 6, 2026. Its market cap has increased by 26.70% in one year.
Market Cap
2.39B
Enterprise Value
3.65B
Revenue
626.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.75
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.39B, a decrease of -63.65%. That is a compound annual growth rate of -18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.39B | 5.38% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | 6.57B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition